HIVID 0.375 (Hivid 0.375 MG)
Generic Name: zalcitabine
Pill with imprint HIVID 0.375 is Pink, Elliptical/Oval and has been identified as Hivid 0.375 MG. It is supplied by Roche Laboratories.
Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for HIVID 0.375
Hivid
- Generic Name
- zalcitabine
- Imprint
- HIVID 0.375
- Strength
- 0.375 MG
- Color
- Pink
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- National Drug Code (NDC)
- 00004-0220 (Discontinued)
More about Hivid (zalcitabine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.